Nuveen Asset Management, LLC Inmune Bio, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 16,518 shares of INMB stock, worth $33,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,518
Previous 16,518
-0.0%
Holding current value
$33,036
Previous $89,000
13.48%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
98Shares Held
6.31MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.63 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.19 Million45.87% of portfolio
-
Ubs Group Ag449KShares$898,4420.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$779,8620.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $35.9M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...